Xyzal M Kid(DT) Tablet
Images are for reference. Actual packaging may vary.
Strip of 10 tablets • TabletPrescription requiredSchedule H
Xyzal M Kid(DT) Tablet
Levocetirizine (2.5mg) + Montelukast (4mg)
₹109.50
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Montelukast 4 mg
+1 more active ingredient
How It Works
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Medicine Strength
4 mg
All Active Ingredients
Montelukast4 mg
Levocetirizine2.5 mg
Uses & Benefits
Medical applications
InflammationAllergicAsthma
Xyzal M Kid (DT) Tablet is a pediatric formulation combining Levocetirizine 2.5 mg and Montelukast 4 mg, designed to provide effective relief from allergic conditions in children. Levocetirizine, a third-generation non-sedating antihistamine, selectively inhibits peripheral H1 receptors, thereby reducing symptoms such as sneezing, nasal congestion, rhinorrhea, and itching associated with allergic rhinitis and chronic urticaria.
Read full descriptionShow less
Montelukast, a leukotriene receptor antagonist, blocks leukotriene D4 at the cysteinyl leukotriene receptor, mitigating airway inflammation and bronchoconstriction commonly observed in asthma and allergic rhinitis. The combination of these agents offers a dual mechanism of action, targeting both histamine-mediated and leukotriene-mediated pathways, resulting in comprehensive symptom control.
Xyzal M Kid (DT) is formulated as a dispersible tablet to facilitate ease of administration in pediatric patients, enhancing compliance. It is indicated for the treatment of allergic rhinitis, chronic urticaria, and mild to moderate asthma in children. The safety profile is favorable, with minimal sedation and gastrointestinal adverse effects reported. Dosage should be as prescribed by a healthcare professional, considering the child’s age and clinical condition.
This combination therapy provides an effective and convenient option for managing pediatric allergic disorders.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
Customer Reviews
0 reviews for Xyzal M Kid(DT) Tablet
